Laura Rufibach

1.5k total citations
17 papers, 218 citations indexed

About

Laura Rufibach is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Laura Rufibach has authored 17 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Genetics. Recurrent topics in Laura Rufibach's work include Muscle Physiology and Disorders (14 papers), RNA modifications and cancer (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Laura Rufibach is often cited by papers focused on Muscle Physiology and Disorders (14 papers), RNA modifications and cancer (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Laura Rufibach collaborates with scholars based in United States, United Kingdom and France. Laura Rufibach's co-authors include Samir S. Deeb, Stephen A. Duncan, Michele A. Battle, Madhuri Hegde, Bradley A. Williams, Douglas E. Albrecht, Babi Ramesh Reddy Nallamilli, Plavi Mittal, Sander Pajusalu and Conrad C. Weihl and has published in prestigious journals such as Journal of Lipid Research, Muscle & Nerve and Human Mutation.

In The Last Decade

Laura Rufibach

14 papers receiving 213 citations

Peers

Laura Rufibach

GENET

CMN

CCM

PHYSI

Yo Okizuka Japan

Vedrana Milić Rašić Serbia

Royston Ong Australia

Plavi Mittal United States

Agnieszka Madej‐Pilarczyk Poland

Curtis A. Nutter United States

Rita Perlingeiro United States

Carola Hedberg Sweden

Casey O. Swoboda United States

Mridul Johari Finland

Yo Okizuka Japan

Laura Rufibach

307 ×1.7

75 ×1.5

GENET

37 ×0.8

CMN

69 ×1.4

CCM

26 ×0.6

PHYSI

Citations per year, relative to Laura Rufibach Laura Rufibach (= 1×) peers Yo Okizuka

Countries citing papers authored by Laura Rufibach

Since Specialization

Citations

This map shows the geographic impact of Laura Rufibach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rufibach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rufibach more than expected).

Fields of papers citing papers by Laura Rufibach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Rufibach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rufibach. The network helps show where Laura Rufibach may publish in the future.

Co-authorship network of co-authors of Laura Rufibach

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rufibach. A scholar is included among the top collaborators of Laura Rufibach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rufibach. Laura Rufibach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rufibach, Laura, et al.. (2023). Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy. Journal of Personalized Medicine. 13(3). 520–520.

Reash, Natalie F., M. James, Lindsay N. Alfano, et al.. (2022). Comparison of strength testing modalities in dysferlinopathy. Muscle & Nerve. 66(2). 159–166. 3 indexed citations

Moore, U., et al.. (2022). Patient reported pregnancy and birth outcomes in genetic neuromuscular diseases. Neuromuscular Disorders. 33(3). 241–249. 4 indexed citations

Tominaga, Kana, Naoomi Tominaga, Eric O. Williams, et al.. (2021). 4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations. iScience. 25(1). 103667–103667. 6 indexed citations

Chakravorty, Samya, et al.. (2020). Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent. Frontiers in Neurology. 11. 559327–559327. 28 indexed citations

Pajusalu, Sander, Nicole J. Lake, Geyu Zhou, et al.. (2019). Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genetics in Medicine. 21(11). 2512–2520. 57 indexed citations

Jacobs, Marni, M. James, Anna Mayhew, et al.. (2019). P.183Functional progression in dysferlinopathy: results of a 3-year natural history study. Neuromuscular Disorders. 29. S102–S102.

Dominov, Janice A., Diane McKenna‐Yasek, Babi Ramesh Reddy Nallamilli, et al.. (2019). Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation. Annals of Clinical and Translational Neurology. 6(4). 642–654. 16 indexed citations

Ankala, Arunkanth, Atchayaram Nalini, Narayanappa Gayathri, et al.. (2017). Detection of dysferlin gene pathogenic variants in the Indian Population in patients predicted to have a dysferlinopathy using a blood-based monocyte assay and clinical algorithm: A model for accurate and cost-effective diagnosis. Annals of Indian Academy of Neurology. 20(3). 302–302. 6 indexed citations

10.

Paradas, Carmen, U. Moore, M. James, et al.. (2016). Clinical outcome study for dysferlinopathy: One-year follow-up. Neuromuscular Disorders. 26. S92–S93. 1 indexed citations

11.

Ankala, Arunkanth, et al.. (2014). Diagnostic overview of blood‐based dysferlin protein assay for dysferlinopathies. Muscle & Nerve. 50(3). 333–339. 13 indexed citations

12.

Albrecht, Douglas E., Laura Rufibach, Bradley A. Williams, et al.. (2013). 6th Dysferlin Conference, 3–6 April 2013, Arlington, Virginia, USA. Neuromuscular Disorders. 24(3). 277–287.

13.

Albrecht, Douglas E., et al.. (2011). 5th Annual Dysferlin Conference 11–14 July 2011, Chicago, Illinois, USA. Neuromuscular Disorders. 22(5). 471–477. 2 indexed citations

14.

Blandin, Gaëlle, Christophe Béroud, Véronique Labelle, et al.. (2011). UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene. Human Mutation. 33(3). E2317–E2331. 36 indexed citations

15.

Albrecht, Douglas E., et al.. (2011). 4th Annual Dysferlin Conference 11–14 September 2010, Washington, USA. Neuromuscular Disorders. 21(4). 304–310. 9 indexed citations

16.

Albrecht, Douglas E., et al.. (2009). 3rd Annual Dysferlin Conference 2–5 June 2009, Boston, Massachusetts, USA. Neuromuscular Disorders. 19(12). 867–873. 3 indexed citations

17.

Rufibach, Laura, Stephen A. Duncan, Michele A. Battle, & Samir S. Deeb. (2006). Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter. Journal of Lipid Research. 47(7). 1463–1477. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact